The Clem Jones Centre for Neurobiology and Stem Cell Research is a translational research centre that develops therapies to treat spinal cord injury, peripheral nerve injuries and dementia.

With widespread community, state and federal government support, a Phase I clinical trial to test a cell transplantation therapy to repair the injured spinal cord commenced in 2024.

Website

https://www.griffith.edu.au/research/institute-biomedicine-glycomics/clem-jones-centre

Organisation type

• University research centre

Number of research staff

20-100 research staff

Address

Building N75, Don Young Road, Griffith University, Nathan, Brisbane QLD 4111

Strengths and capabilities

• Expertise in brain and spinal cord injury
• 3D bioprinting
• Cell transplantation therapy
• Clinical trials

Facilities and major equipment

• Physical Containment Class 2 (PC2) laboratory
• Live cell imaging
• Microscopy suite
• Human cell culture facility
• Mammalian cell culture facility
• 3D bioprinters

Lead researchers

• Professor James St John, NHMRC Marshall and Warren Innovation Award 2019
• Dr Mo Chen, Research Australia Discovery Award 2020–2021

Achievements of the centre

• A clinical trial to test an olfactory cellular nerve bridge transplantation therapy to treat spinal cord injury.

Key science sectors

More information about the sectors this centre is involved in:

• Biotechnology
• Health and medical